Interleukin 1: the choreographer for the restenotic ballet

• References

• 1 Libby P, Ganz P. Restenosis revisited – new targets, new therapies. N Engl J Med 1997; 337: 418-9.
• 2 Erbel R, Haude M, Hopp HW, Franzen D, Rupprecht HJ, Heublein B, Fischer K, de Jaegere P, Serruys P, Rutsch W, Probst P. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. N Engl J Med 1998; 339: 1672-8.
• 3 Jorgensen E, Kelbaek H, Helqvist S. et al. Low restenosis rate of the NIR coronary stent: results of the Danish multicenter stent study (DANSTENT)—a randomized trial comparing a first-generation stent with a second-generation stent. Am Heart J 2003; 145: e5.
• 4 Carrozza Jr. JP, Kuntz RE, Levine MJ. et al. Angiographic and clinical outcome of intra-coronary stenting: immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992; 20: 328-37.
• 5 Moreno PR, Palacios IF, Leon MN, Rhodes J, Fuster V, Fallon JT. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 1999; 84: 462-6. A9
• 6 Wang X, Romanic AM, Yue TL, Feuerstein GZ, Ohlstein EH. Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty. Biochem Biophys Res Commun 2000; 271: 138-43.
• 7 Ward MR, Agrotis A, Kanellakis P, Dilley R, Jennings G, Bobik A. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury. Arterioscler Thromb Vasc Biol 1997; 17: 2461-70.
• 8 Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994; 75: 539-45.
• 9 Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo . Nature 1993; 362: 844-6.
• 10 Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992; 89: 507-11.
• 11 Loppnow H, Bil R, Hirt S, Schonbeck U, Herzberg M, Werdan K, Rietschel ET, Brandt E, Flad HD. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 1998; 91: 134-41.
• 12 Crook MF, Newby AC, Southgate KM. Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture. Atherosclerosis 2000; 150: 33-41.
• 13 Pierce GF. Macrophages: important physiologic and pathologic sources of polypeptide growth factors. Am J Respir Cell Mol Biol 1990; 2: 233-4.
• 14 Kaiser M, Younge B, Bjornsson J, Goronzy JJ, Weyand CM. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Path-ol 1999; 155: 765-74.
• 15 Knudsen E, Iversen PO, Van Rooijen N, Benestad HB. Macrophage-dependent regulation of neutrophil mobilization and chemotaxis during development of sterile peritonitis in the rat. Eur J Haematol 2002; 69: 284-96.
• 16 Dinarello CA. Biology of interleukin 1. FASEB J 1988; 2: 108-15.
• 17 Moreno PR, Bernardi VH, Lopez-Cuellar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996; 94: 3098-102.
• 18 Pietersma A, Kofflard M, de Wit LE, Stijnen T, Koster JF, Serruys PW, Sluiter W. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995; 91: 1320-5.
• 19 Loppnow H, Westphal E, Buchhorn R, Wessel A, Werdan K. Interleukin-1 and related proteins in cardiovascular disease in adults and children. Shock 2001; 16: 3-9.
• 20 Pogliaghi G, Tacchini L, Anzon E, Radice L, Bernelli-Zazzera A. Heat shock activation of NFkB in rat liver is mediated by interleukin-1. FEBS Lett 1995; 372: 181-4.
• 21 Zhu Y, Liao HL, Lin JH, Verna L, Stemerman MB. Low-density lipoprotein augments inter-leukin-1-induced vascular adhesion molecule expression in human endothelial cells. Atherosclerosis 1999; 144: 357-65.
• 22 Sluiter W, Pietersma A, Lamers JM, Koster JF. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol 1993; 22: S37-44.
• 23 Andoh A, Takaya H, Saotome T, Shimada M, Hata K, Araki Y, Nakamura F, Shintani Y, Fujiyama Y, Bamba T. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 2000; 119: 211-9.
• 24 Zohlnhofer D, Brand K, Schipek K, Pogatsa-Murray G, Schomig A, Neumann FJ. Adhesion of monocyte very late antigen-4 to endothelial vascular cell adhesion molecule-1 induces interleukin-1beta-dependent expression of interleukin-6 in endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20: 353-9.
• 25 Ko Y, Totzke G, Gouni-Berthold I, Sachinidis A, Vetter H. Cytokine-inducible growth factor gene expression in human umbilical endothelial cells. Mol Cell Probes 1999; 13: 203-11.
• 26 Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann FJ, von Beckerath N, Bottiger C, Duff GW, Schomig A. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000; 36: 2168-73.
• 27 Francis SE, Camp NJ, Burton AJ, Dewberry RM, Gunn J, Stephens-Lloyd A, Cumberland DC, Gershlick A, Crossman DC. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart 2001; 86: 336-40.
• 28 Marculescu R, Mlekusch W, Exner M. et al. Interlukin-1 cluster combined genotype and restonisis after balloon angioplasty. Thromb Haemost 2003; 90: 2.
• 29 Mandinov L, Mandinova A, Kyurkchiev S. et al. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci USA 2003; 100: 6700-05.
• 30 Mandinova A, Soldi R, Graziani I. et al. S100A13 mediates the copper-dependent stress-induced release of IL-1{alpha} from both human U937 and murine NIH 3T3 cells. J Cell Sci 2003; 116: 2687-96.
• 31 Pan Q, Kleer CG, van Golen KL. et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res 2002; 62: 4854-9.
• 32 Volker W, Dorszewski A, Unruh V, Robenek H, Breithardt G, Buddecke E. Copper-induced inflammatory reactions of rat carotid arteries mimic restenosis/arteriosclerosis-like neointima formation. Atherosclerosis 1997; 130: 29-36.
• 33 Tanigawa N, Sawada S, Kobayashi M. Reaction of the aortic wall to six metallic stent materials. Acad Radiol 1995; 2: 379-84.
• 34 Voronov E, Shouval DS, Krelin Y. et al. IL-1 is required for tumor invasiveness and angio-genesis. Proc Natl Acad Sci U S A 2003; 100: 2645-50.